- AU$816.60m
- AU$802.93m
- AU$0.79m
Annual balance sheet for Race Oncology, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Short Term Investments | 9.32 | 33.5 | 21.5 | 17.2 | 13.7 |
| Net Total Receivables | 0.128 | 0.062 | 1.7 | 0.106 | 0.03 |
| Prepaid Expenses | |||||
| Total Current Assets | 10.6 | 34.2 | 23.5 | 17.4 | 15 |
| Net Intangible Assets | |||||
| Total Assets | 14.2 | 37.5 | 26.6 | 20.2 | 17.5 |
| Accounts Payable | |||||
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 0.523 | 1.42 | 1.15 | 1.87 | 1.45 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 0.523 | 1.42 | 1.15 | 1.92 | 1.48 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 13.7 | 36.1 | 25.5 | 18.3 | 16 |
| Total Liabilities & Shareholders' Equity | 14.2 | 37.5 | 26.6 | 20.2 | 17.5 |
| Total Common Shares Outstanding |